Episode 232 -- June 2025 -- Part 2 AFP: American Family Physician

Nocturia (1:30), assessing the risk of atrial fibrillation (5:00), zoledronate reduces fracture risk (7:20), endometrial cancer (10:10), diabetes-related foot infections (13:50), and at-home gonorrhea and chlamydia testing (15:50).

Acute monoarthritis (1:30), improving adverse drug reaction reporting (6:30), inappropriate use of oral antiplatelet drugs (9:50), long-term opioid therapy (12:40), treating Clostridioides difficile infection (17:10), and lecanemab for Alzheimer disease (19:00).

Migraine headache prophylaxis (1:30), atrial fibrillation with stable coronary artery disease (6:10), health maintenance in postmenopausal women (8:50), topical testosterone (13:50), pain control in primary dysmenorrhea (17:50), and obstructive sleep apnea in children (20:00).

Trigeminal neuralgia (1:30), early medication abortion (4:30), sodium-glucose cotransporter-2 inhibitors (6:00), female sexual dysfunction (8:40), per- and polyfluoroalkyl substances (12:30), and methotrexate for juvenile idiopathic arthritis (17:20).

Buprenorphine for opioid use disorder (1:30), triptans for acute migraine (5:30), premenstrual syndrome (6:50), pain management for IUD insertion (11:00), liver fibrosis stage in chronic hepatitis C infection (12:30), and cold water immersion for muscle soreness (14:30).

Labor management (1:30), acute migraine headache (4:00), tirzepatide for sleep apnea (8:20), options for unintended pregnancy (11:20), artificial intelligence scribes (15:00), and testosterone replacement in men with sexual dysfunction (16:50).

Down syndrome (1:30), zuranolone for postpartum depression (7:50), muscle relaxants for chronic pain (10:20), temporal artery ultrasound (12:00), pretravel consultation (15:40), and high-flow nasal cannula for bronchiolitis (19:20).

Nicotine electronic cigarettes (1:30), acute bronchitis (4:10), berdazimer (6:40), cardiac rehabilitation (11:40), chronic pelvic pain (13:50), and mineralocorticoid receptor antagonists in heart failure (22:10).

Fatigue in kidney failure (1:30), gastric cancer (3:50), carpal tunnel injections (6:50), sudden infant death syndrome (9:30), plantar fasciitis (13:20), and measuring ceramide to predict cardiovascular events (15:10).

Cardiovascular risk prediction (1:30), topical steroids for phimosis (3:20), genital warts (7:10), psilocybin for depression (12:00), lower extremity abnormalities in children (13:30), and atrial fibrillation (22:10).